Cargando…
Therapeutic Evaluation of Antibody-Based Targeted Delivery of Interleukin 9 in Experimental Pulmonary Hypertension
Background and Aims: Pulmonary hypertension (PH) is a heterogeneous disorder associated with poor prognosis. For the majority of patients, only limited therapeutic options are available. Thus, there is great interest to develop novel treatment strategies focusing on pulmonary vascular and right vent...
Autores principales: | Gouyou, Baptiste, Grün, Katja, Kerschenmeyer, Anne, Villa, Alessandra, Matasci, Mattia, Schrepper, Andrea, Pfeil, Alexander, Bäz, Laura, Jung, Christian, Schulze, P. Christian, Neri, Dario, Franz, Marcus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037792/ https://www.ncbi.nlm.nih.gov/pubmed/33801620 http://dx.doi.org/10.3390/ijms22073460 |
Ejemplares similares
-
Sortase-Mediated Site-Specific Modification of Interleukin-2
for the Generation of a Tumor-Targeting Acetazolamide–Cytokine
Conjugate
por: Gouyou, Baptiste, et al.
Publicado: (2020) -
Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade
por: Dakhel, Sheila, et al.
Publicado: (2019) -
A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo
por: Ongaro, Tiziano, et al.
Publicado: (2020) -
Serum Biomarkers of Cardiovascular Remodelling Reflect Extra-Valvular Cardiac Damage in Patients with Severe Aortic Stenosis
por: Bäz, Laura, et al.
Publicado: (2020) -
Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A(+) Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling
por: Bäz, Laura, et al.
Publicado: (2021)